Three ileus cases associated with the use of dipeptidyl peptidase‐4 inhibitors in diabetic patients

Three ileus cases associated with the use of dipeptidyl peptidase‐4 inhibitors in diabetic patients

Dipeptidyl peptidase (DPP)‐4 inhibitors are a new class of antidiabetic drugs that increase incretin hormone levels to enhance blood sugar level‐dependent insulinotropic effects, suppress glucagon action, and reduce bowel motility. These incretin effects are ideal for blood sugar control. However, t...

Full description

Bibliographic Details
Main Authors:	Kanasaki, Keizo, Konishi, Kazunori, Hayashi, Ranji, Shiroeda, Hisakazu, Nomura, Tomoe, Nakagawa, Atsushi, Nagai, Takako, Takeda‐Watanabe, Ai, Ito, Hiroki, Tsuda, Shin‐ichi, Kitada, Munehiro, Fujii, Mizue, Kanasaki, Megumi, Nishizawa, Makoto, Nakano, Yasuharu, Tomita, Yasuto, Ueda, Nobuhiko, Kosaka, Takeo, Koya, Daisuke
Format:	Online
Language:	English
Published:	Wiley-Blackwell 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020265/

Similar Items

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
by: Shi, Sen, et al.
Published: (2016)

Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
by: Kanasaki, Megumi, et al.
Published: (2011)

N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
by: Kanasaki, Keizo, et al.
Published: (2014)

N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition
by: Nagai, Takako, et al.
Published: (2014)

Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen
by: Nitta, Kyoko, et al.
Published: (2016)

Diabetic angiopathy and angiogenic defects
by: Xu, Ling, et al.
Published: (2012)

Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes
by: Kitada, Munehiro, et al.
Published: (2011)

Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis
by: Srivastava, Swayam Prakash, et al.
Published: (2016)

Autophagy as a Therapeutic Target in Diabetic Nephropathy
by: Tanaka, Yuki, et al.
Published: (2012)

Sirtuins and renal diseases: relationship with aging and diabetic nephropathy
by: Kitada, Munehiro, et al.
Published: (2012)

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
by: Srivastava, Swayam Prakash, et al.
Published: (2013)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
by: Kanasaki, Keizo, et al.
Published: (2013)

Cancer biology in diabetes
by: Sen, Shi, et al.
Published: (2014)

The Relevance of the Renin-Angiotensin System in the Development of Drugs to Combat Preeclampsia
by: Ueki, Norikazu, et al.
Published: (2015)

Lipid mediators in diabetic nephropathy
by: Srivastava, Swayam Prakash, et al.
Published: (2014)

Specific Activation of K-RasG12D Allele in the Bladder Urothelium Results in Lung Alveolar and Vascular Defects
by: Ayala de la Peña, Francisco, et al.
Published: (2014)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
by: Garg, Vishvas
Published: (2011)

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
by: Das, Siddhartha Shankar, et al.
Published: (2014)

Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
by: Shoombuatong, Watshara, et al.
Published: (2015)

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
by: Singh, Awadhesh Kumar
Published: (2014)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
by: Kim, Na-Hyung, et al.
Published: (2014)

Renal Protective Effects of Resveratrol
by: Kitada, Munehiro, et al.
Published: (2013)

SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
by: Kitada, Munehiro, et al.
Published: (2013)

A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells
by: Wesley, Umadevi V., et al.
Published: (1999)

Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
by: Jang, Yun-Mi, et al.
Published: (2011)

Linagliptin—A Novel Dipeptidyl Peptidase Inhibitor for Type 2 Diabetes Therapy
by: Gallwitz, Baptist
Published: (2012)

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
by: Joo, Kwon Wook, et al.
Published: (2013)

Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
by: Lin, Ching-Ting, et al.
Published: (2010)

A New TASK for Dipeptidyl Peptidase-like Protein 6
by: Nadin, Brian M., et al.
Published: (2013)

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin
by: Capuano, Annalisa, et al.
Published: (2013)

Synergistic effect of α‐glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment
by: Horikawa, Yukio, et al.
Published: (2010)

Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
by: Avogaro, Angelo, et al.
Published: (2014)

Dipeptidyl Peptidase 10, a Novel Prognostic Marker in Colorectal Cancer
by: Park, Heae Surng, et al.
Published: (2013)

Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation
by: Han, Ruijun, et al.
Published: (2015)

Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis
by: Schulz, Kirsten, et al.
Published: (2015)

Dipeptidyl Peptidase-4 Inhibition May Stimulate Progression of Carcinoid Tumor
by: Pech, Vladimir, et al.
Published: (2015)

C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy
by: Demir, Sevin, et al.
Published: (2016)

Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease
by: Yang, Guang, et al.
Published: (2016)

Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
by: Nojima, Hiroyuki, et al.
Published: (2016)

Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis
by: Liu, Xin, et al.
Published: (2016)